Market revenue in 2023 | USD 36.3 million |
Market revenue in 2030 | USD 43.7 million |
Growth rate | 2.7% (CAGR from 2023 to 2030) |
Largest segment | Cardiopulmonary perfusion system |
Fastest growing segment | Cardiopulmonary Perfusion System |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Cardiopulmonary Perfusion System, Cell Perfusion System, Ex-Vivo Organ Perfusion System |
Key market players worldwide | Getinge AB ADR, Medtronic PLC, LivaNova PLC, Terumo Corp, Nipro Corp, Fresenius Medical Care AG, Repligen Corp, Spectrum Brands Holdings Inc, Merck KGaA, Xvivo Perfusion AB |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to perfusion systems market will help companies and investors design strategic landscapes.
Cardiopulmonary perfusion system was the largest segment with a revenue share of 43.25% in 2023. Horizon Databook has segmented the France perfusion systems market based on cardiopulmonary perfusion system, cell perfusion system, ex-vivo organ perfusion system covering the revenue growth of each sub-segment from 2018 to 2030.
The competition in France’s perfusion system market is intense due to a rapidly growing geriatric population at a high risk of developing Acute Respiratory Distress Syndrome (ARDS), making it one of the EU’s fastest-aging countries and a favorable market for perfusion systems.
As per a French national hospital database (Programme de Médicalisation des Systèmes d’Information, or PMSI), in 2021, the crude incidence of ARDS was 6.7 cases per 100,000 in people aged 18 to 40 and 51.9 cases per 100,000 in people aged 68 to 76.
The demand for perfusion systems is anticipated to be driven over the projected period by an increase in the elderly population and a rise in the prevalence of heart illnesses. According to an article by Béatrice Madeline in March 2023, the demographic makeup of France is swiftly changing, with 26% of its people aged over 60 years, representing one in every four residents. ket in France.
Horizon Databook provides a detailed overview of country-level data and insights on the France perfusion systems market , including forecasts for subscribers. This country databook contains high-level insights into France perfusion systems market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account